Smoking Increases Side Effect, Recurrence Risk in Prostate Cancer

Share this content:

the ONA take:

The fact that smoking contributes to a poor prognosis in many diseases and conditions is well-known. A recent study from Memorial Sloan Kettering Cancer Center in New York City confirmed the effects on smoking on patients with prostate cancer.

Those who smoke have increased risks of experiencing treatment-related side effects and cancer recurrences, or even dying from the disease. These researchers studied 2,358 patients who underwent external beam radiotherapy for prostate cancer between 1988 and 2005, of which 2,156 had a history of smoking.

Risk of cancer relapse was 40% higher and risk of metastasis and cancer-related death was more than 2-times higher in patients who were current smokers compared with patients who were never smokers.

Current and former smokers also had a higher likelihood of experiencing side effects, such as urinary toxicity, related to radiotherapy. "Less optimal tumor control outcomes among smokers could possibly be explained by the influence of less oxygen concentration within the treated tumors among smokers, which is known to lead to less sensitivity of the cells being killed off by radiation treatments," the researchers noted.

Guanfacine may help with smoking cessation
Recent study confirmed the effects on smoking on patients with prostate cancer.
Among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and of developing future cancer recurrences, or even dying from prostate cancer. Patients were classified as never smokers, current smokers, former smokers, and current smoking unknown.
READ FULL ARTICLE From Medical News Today
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs